Description
Sports medicines are known as the branch of medicines that deals with the physical health and curing or prevention of sports relates injuries. In almost a last decade it has been noticed that people are more aware about health. Increasing health education in school and different programs on social media has led to increase the awareness about health. People have started adopting sports as the mean to maintain the health and as extracurricular activity. Not only young but elderly people have also adopted sports. This has led to increase the number of sports related injuries across the globe.
Notably, rising prevalence of sports injuries is the key factor driving the sports medicine market. According to US centers for diseases control, around 10 % of kids and teen participating in the sports suffer from minor or major type of injury. Majority of the sports injury occur during 12-16 yr. age.
Other push factors such as, increasing number of sports medicine associations, increasing awareness, and technological development are also propelling the growth of the market. Increasing awareness is the most important part in development of the healthcare sector. Increase in the sports and health related education amongst the people has encourage to play different sports. Many aged people started participating in the different sports. Knowledge about enhancing health, risk of diseases and various advantages of playing sports has encourage people to play different sports.
The global sports medicines market is expected to reach USD 9,655.6 million by 2023 at a CAGR of 8.9% during the forecast period.
On the basis of products, market is segmented into joint reconstructive & repair products, support & recovery products, accessories & consumables, and others. The joint reconstructive & repair products segment accounted for the largest market share of 40% during the forecast period.
On the basis of application, market is segmented into shoulder treatment, knee treatment, hip treatment, spine treatment, others. Knee treatment market is expected to grow at a CAGR of 9.3% from 2016 to 2023.
On the basis of regions, the market is segmented into Americas, Europe, Asia-Pacific and the Middle East & Africa. Americas captured a largest market share of around 39.2% in 2016 globally. The shoulder treatment market for North America was estimated at USD 562.8 Million in 2016 and is expected to reach at USD 1,055.4 Million by 2023 at a CAGR of 8.9%.
Key Players
Medtronic, Stryker, Arthrex, Inc, Zimmer Biomet, Conmed Corporation, DePuy Synthes, GE Healthcare, and Smith & Nephew plc.
Study objectives
• To provide detailed analysis of the market structure along with forecast of the various segments and sub-segments of the global sports medicines market
• To provide insights about factors influencing and affecting the market growth
• To provide historical and forecast revenue of the market segments and sub-segments with respect to countries
• To provide historical and forecast revenue of the market segments based on product, application, procedures, end user, and regions for the global sports medicines market.
• To provide strategic profiling of key players in the market, and comprehensively analysing their market share, core competencies, and drawing a competitive landscape for the market
• To provide economic factors that influences the global sports medicines market
• To provide detailed analysis of the value chain and supply chain of the global sports medicines market
Target Audience
• Sports medicines manufacturers
• Sports medicines Suppliers
• Sports medicines Distributors
• Pharmaceutical companies
• Research and Development (R&D) Companies
• Medical Research Laboratories
• Academic Medical Institutes and Universities
Key Findings
• Americas accounted for the largest market share in the global sports medicines market, USD 1,883.6 million in 2016 and expected to reach by USD 3,701.2 million by 2023 at a fastest CAGR of 8.6%
• Support & Recovery Product is the fastest growing segment with a CAGR of and 9.2% in the global sports medicines market, by product
• Ambulatory Care is growing at a CAGR of 9.3% in the global sports medicines market.
The reports also covers regional analysis
• Americas
o North America
§ US
§ Canada
o South America
• Europe
o Germany
o France
o U.K.
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Republic of Korea
o Rest of Asia-Pacific
• Middle East & Africa
o Middle East
o Africa
1 Report Prologue
2 Introduction
2.1 Scope of Study
2.2 Research Objective
2.3 Assumptions & Limitations
2.3.1 Assumptions
2.3.2 Limitations
2.4 Market Structure
3 Research Methodology
3.1 Primary Research
3.2 Secondary Research
4 Market Dynamics
4.1 Drivers
4.1.1 Increasing prevalence of Sports Injuries
4.1.2 Increasing number of Sports Medicine Associations
4.1.3 Increasing Awareness
4.1.4 Technological development
4.2 Restraints
4.2.1 Lack of skilled professionals
4.2.2 High cost
4.3 Opportunities
4.3.1 Rise in influx of athletes
4.3.2 Technological advances in sports medicines
4.4 Threats
4.4.1 Introduction of small and medium sized companies
5 Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
6 Global Sports Medicine Market, By Product
6.1 Introduction
6.1.1 Joint Reconstructive & Repair Products
6.1.2 Body Support and recovery products
6.1.3 Accessories
7 Global Sports Medicines Market, By Application
7.1 Introduction
7.1.1 Shoulder Treatment
7.1.2 Knee Treatment
7.1.3 Hip Treatment
7.1.4 Spine Treatment
8 Global Sports Medicines Market, by Procedures
8.1 Introduction
8.1.1 Tendinosis
8.1.2 Tendon to Bone
8.1.3 Cartilage repair
9 Global Sports Medicines Market, By End User
9.1 Introduction
9.1.1 Hospital & Emergency Care
9.1.2 Trauma center
9.1.3 Ambulatory Care
10 Global Sports Medicine Market, By Region
10.1 Introduction
10.2 North America
10.2.1 Introduction
10.2.2 U.S.
10.2.3 Canada
10.2.4 South America
10.3 Europe
10.3.1 Introduction
10.3.2 Germany
10.3.3 France
10.3.4 U.K.
10.3.5 Italy
10.3.6 Spain
10.3.7 Rest of Western Europe
10.3.8 Eastern Europe
10.4 Asia-Pacific
10.4.1 Introduction
10.4.2 Japan
10.4.3 China
10.4.4 India
10.4.5 Republic of Korea
10.4.6 Australia
10.4.7 Rest of Asia Pacific
10.5 Middle East & Africa
10.5.1 Introduction
10.5.2 Middle East
10.5.3 Africa
11 Company Landscape
11.1 Introduction
12 Company Profile
12.1 Medtronics
12.1.1 Company Overview
12.1.2 Product/Business Segment Overview
12.1.3 Financial Overview
12.1.4 Key Development
12.2 Stryker
12.2.1 Company Overview
12.2.2 Product/Business Segment Overview
12.2.3 Financial Overview
12.2.4 Key Development
12.3 Zimmer Biomet
12.3.1 Company Overview
12.3.2 Product/Business Segment Overview
12.3.3 Financial Overview
12.3.4 Key Development
12.4 Conmed Corporation
12.4.1 Company Overview
12.4.2 Product/Business Segment Overview
12.4.3 Financial Overview
12.4.4 Key Development
12.5 DePuy Synthes
12.5.1 Company Overview
12.5.2 Product/Business Segment Overview
12.5.3 Financial Overview
12.5.4 Key Development
12.6 GE Healthcare
12.6.1 Company Overview
12.6.2 Product/Business Segment Overview
12.6.3 Financial Overview
12.6.4 Key Development
12.7 Smith & Nephew plc
12.7.1 Company Overview
12.7.2 Product Overview
12.7.3 Financials
12.7.4 Key Developments
12.8 Arthrex, Inc.
12.8.1 Company Overview
12.8.2 Product/Business Segment Overview
12.8.3 Financial Overview
12.8.4 Key Development
